CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

How does it work

CPHI Online is a global marketplace.

The place where global Pharma professionals come to source new partners, look for products and solutions and make connections – all year round. It’s also a go-to place to learn about the latest trends, developments and news in the Pharma industry.

If your company wants to do business with the global Pharma industry, this is the place to be.

Why CPHI Online

CPHI Online is the largest global marketplace where the pharma community comes to source new partners, showcase products and solutions, and make connections.

Direct access to your target Pharma audience
Effective reporting
Multi or single channel campaigns
Measurable communications and results
Scalable multi-channel campaigns
Build brand credibility
Generate leads
Access to expert analysts
Promotional campaign around your content
Innovative and memorable content

Trusted by over 7,000 pharma companies, including:

Top Products

CPHI Pharmaceutical Products, Companies and News

From ambition to action: accelerating environmental sustainability in biomanufacturing

News From ambition to action: accelerating environmental sustainability in biomanufacturing

BioPhorum Sustainability introduces a new tool to improve monitoring of heating, ventilation and air conditioning (HVAC) systems for more sustainable manufacturing practices.

Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen

News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen

Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.

Women in Pharma: The philosophy of pharmaceutical leadership

News Women in Pharma: The philosophy of pharmaceutical leadership

In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.